NSE / BSEHealthcare
β‚Ή1468.95-15.35-1.03%
P/E51.8Mkt Capβ‚Ή12.76 K CrEV/EBITDA29.5

Rainbow Children's Medicare Limited

P/E51.8Mkt Capβ‚Ή12.76 K CrEV/EBITDA29.5
Company Profile

Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–Ό 4.42% over 1Y
Monthly Returns

Historically, May has averaged the highest return (+7.4%); Jan the lowest (-3.2%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-13.8%Negative MonthJan 2026: -13.82%+4.4%Positive MonthFeb 2026: +4.42%-2.0%Negative MonthMar 2026: -2.04%+7.8%Positive MonthApr 2026: +7.76%+8.1%Positive MonthMay 2026: +8.15%+4.2%Positive MonthJun 2026: +4.20%+4.0%*Positive MonthJul 2026: +3.98%β€”β€”β€”β€”β€”
2025-4.6%Negative MonthJan 2025: -4.55%-13.0%Negative MonthFeb 2025: -12.97%+12.6%Positive MonthMar 2025: +12.59%-1.3%Neutral MonthApr 2025: -1.27%+1.6%Neutral MonthMay 2025: +1.62%+11.3%Positive MonthJun 2025: +11.32%-2.5%Negative MonthJul 2025: -2.51%-1.4%Neutral MonthAug 2025: -1.41%-9.8%Negative MonthSep 2025: -9.76%+1.0%Neutral MonthOct 2025: +0.97%-0.7%Neutral MonthNov 2025: -0.66%-3.0%Negative MonthDec 2025: -2.97%
2024+2.0%Neutral MonthJan 2024: +1.99%+11.4%Positive MonthFeb 2024: +11.45%-4.3%Negative MonthMar 2024: -4.29%+5.9%Positive MonthApr 2024: +5.89%-5.3%Negative MonthMay 2024: -5.25%-4.3%Negative MonthJun 2024: -4.28%-5.0%Negative MonthJul 2024: -4.98%+7.0%Positive MonthAug 2024: +7.02%+10.3%Positive MonthSep 2024: +10.26%+15.4%Positive MonthOct 2024: +15.35%-1.6%Neutral MonthNov 2024: -1.60%-5.7%Negative MonthDec 2024: -5.67%
2023+3.6%Positive MonthJan 2023: +3.61%-3.4%Negative MonthFeb 2023: -3.40%-1.4%Neutral MonthMar 2023: -1.42%+8.2%Positive MonthApr 2023: +8.22%+25.1%Positive MonthMay 2023: +25.12%-3.2%Negative MonthJun 2023: -3.18%+14.0%Positive MonthJul 2023: +13.99%-2.9%Negative MonthAug 2023: -2.91%-2.8%Negative MonthSep 2023: -2.84%+3.4%Positive MonthOct 2023: +3.36%+0.9%Neutral MonthNov 2023: +0.87%+11.2%Positive MonthDec 2023: +11.17%
2022β€”β€”β€”β€”β€”-5.9%Negative MonthJun 2022: -5.87%+5.0%Positive MonthJul 2022: +4.97%+24.7%Positive MonthAug 2022: +24.68%+3.7%Positive MonthSep 2022: +3.70%+9.0%Positive MonthOct 2022: +9.02%+8.5%Positive MonthNov 2022: +8.47%-1.0%Neutral MonthDec 2022: -0.96%
AvgΒ±SD-3.2%Β±6.9%-0.1%Β±9.1%+1.2%Β±6.7%+5.2%Β±3.8%+7.4%Β±11.3%+0.4%Β±6.4%+3.1%Β±6.6%+6.8%Β±11.0%+0.3%Β±7.4%+7.2%Β±5.6%+1.8%Β±4.0%+0.4%Β±6.4%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 5 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 1.113x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή1.46 K Crβ–² 17.6%
EBITDA Growthβ€”
Net Profitβ‚Ή238.00 Crβ–² 10.7%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 325.0%
Revenue CAGR 5Y12.2%
EBITDA CAGR 5Y15.5%
Net Profit CAGR 5Y24.8%
NP Growth 1Y10.7%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή1.46 K Crβ€”β‚Ή238.00 Crβ€”β€”16.0%17.6%10.7%
Mar 2024β‚Ή1.24 K Crβ€”β‚Ή215.00 Crβ€”β€”16.7%11.0%4.4%
Mar 2023β‚Ή1.11 K Crβ€”β‚Ή206.00 Crβ€”β€”18.9%20.4%45.1%
Mar 2022β‚Ή925.00 Crβ€”β‚Ή142.00 Crβ€”β€”22.7%50.7%189.8%
Mar 2021β‚Ή614.00 Crβ€”β‚Ή49.00 Crβ€”β€”10.5%-11.7%-31.0%
Mar 2020β‚Ή695.00 Crβ€”β‚Ή71.00 Crβ€”β€”17.1%28.0%18.3%
Mar 2019β‚Ή543.00 Crβ€”β‚Ή60.00 Crβ€”β€”14.9%35.1%66.7%
Mar 2018β‚Ή402.00 Crβ€”β‚Ή36.00 Crβ€”β€”10.3%71.8%111.8%
Mar 2016β‚Ή234.00 Crβ€”β‚Ή17.00 Crβ€”β€”6.0%58.1%-37.0%
Mar 2015β‚Ή148.00 Crβ€”β‚Ή27.00 Crβ€”β€”15.1%β€”β€”

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales1482344025436956149251,1141,2371,4551,479
Total Expenses110204332430486449626729820976998
EBIT / Operating Profit393070112209166299385417479481
OPM %26%13%17%21%30%27%32%35%34%33%33%
Other Income101610812122127374954
Finance Costs234646445355597469
Depreciation & Amortisation718283665687784105132132
Profit Before Tax4024477910966190273289322334
Tax %33%28%22%25%35%25%25%25%26%26%-
Net Profit / PAT271736607149142206215238246
EPS (β‚Ή)28.6518.398.3013.5616.1211.2415.1320.2821.1723.4024.26
Dividend Payout %7%11%12%7%12%0%13%15%14%13%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Rainbow Children's Medicare Limitedthis co.β‚Ή12.76 K Crβ‚Ή1.46 K Cr51.808.0629.4717.6%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Rainbow Children's Medicare Limited and the metrics that matter.

Browse the full Equiscale Academy